Joseph H. Killoran, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 16 | 2023 | 1680 | 0.840 |
Why?
|
| Radiosurgery | 6 | 2023 | 1346 | 0.590 |
Why?
|
| Four-Dimensional Computed Tomography | 3 | 2012 | 141 | 0.460 |
Why?
|
| Thoracic Wall | 1 | 2014 | 204 | 0.390 |
Why?
|
| Movement | 5 | 2012 | 1490 | 0.390 |
Why?
|
| Radiation Oncology | 4 | 2023 | 573 | 0.380 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2018 | 2056 | 0.360 |
Why?
|
| Radiotherapy, Conformal | 5 | 2017 | 549 | 0.320 |
Why?
|
| Respiratory Mechanics | 2 | 2008 | 722 | 0.280 |
Why?
|
| Chest Pain | 1 | 2014 | 1099 | 0.280 |
Why?
|
| Radiometry | 3 | 2014 | 817 | 0.270 |
Why?
|
| Lung Neoplasms | 13 | 2022 | 13576 | 0.260 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 8 | 2022 | 5422 | 0.260 |
Why?
|
| Radiotherapy Dosage | 9 | 2022 | 2922 | 0.250 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2012 | 1226 | 0.240 |
Why?
|
| Radiopharmaceuticals | 5 | 2018 | 2734 | 0.220 |
Why?
|
| Tattooing | 1 | 2023 | 57 | 0.220 |
Why?
|
| Artifacts | 2 | 2011 | 1930 | 0.210 |
Why?
|
| Algorithms | 7 | 2011 | 14154 | 0.210 |
Why?
|
| Software | 1 | 2017 | 4453 | 0.210 |
Why?
|
| Radiotherapy, Intensity-Modulated | 5 | 2022 | 812 | 0.200 |
Why?
|
| Positron-Emission Tomography | 8 | 2012 | 6670 | 0.200 |
Why?
|
| Quality Improvement | 1 | 2017 | 3858 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2012 | 20765 | 0.180 |
Why?
|
| Thoracic Neoplasms | 2 | 2020 | 269 | 0.160 |
Why?
|
| Radiotherapy | 2 | 2019 | 1509 | 0.160 |
Why?
|
| Lung | 5 | 2017 | 10089 | 0.150 |
Why?
|
| Collagen Diseases | 1 | 2017 | 39 | 0.150 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2023 | 459 | 0.140 |
Why?
|
| Radiation Pneumonitis | 1 | 2017 | 100 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 2 | 2022 | 2923 | 0.140 |
Why?
|
| Tumor Burden | 4 | 2016 | 1913 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2011 | 4076 | 0.130 |
Why?
|
| Motion | 2 | 2011 | 789 | 0.130 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2020 | 346 | 0.130 |
Why?
|
| Radiation Dosage | 4 | 2022 | 1974 | 0.130 |
Why?
|
| Software Validation | 1 | 2014 | 59 | 0.120 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2020 | 672 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2001 | 1320 | 0.110 |
Why?
|
| Critical Pathways | 1 | 2017 | 476 | 0.110 |
Why?
|
| Risk Management | 1 | 2017 | 558 | 0.110 |
Why?
|
| Esophageal Neoplasms | 2 | 2018 | 1676 | 0.100 |
Why?
|
| Rib Fractures | 1 | 2014 | 124 | 0.100 |
Why?
|
| Phantoms, Imaging | 4 | 2019 | 2528 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2018 | 1277 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2018 | 740 | 0.090 |
Why?
|
| Pneumonectomy | 1 | 2018 | 1158 | 0.090 |
Why?
|
| Helium | 1 | 2011 | 119 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2017 | 1397 | 0.090 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 20224 | 0.090 |
Why?
|
| Diaphragm | 1 | 2011 | 359 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2017 | 1161 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2020 | 3125 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2008 | 6277 | 0.080 |
Why?
|
| Heart | 1 | 2020 | 4449 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2014 | 1226 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2181 | 0.070 |
Why?
|
| Infrared Rays | 1 | 2008 | 249 | 0.070 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 59686 | 0.070 |
Why?
|
| Organs at Risk | 2 | 2022 | 368 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2012 | 1218 | 0.060 |
Why?
|
| Automation | 2 | 2023 | 588 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2565 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 11254 | 0.060 |
Why?
|
| Humans | 35 | 2023 | 768393 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2022 | 81801 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 5443 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 2018 | 6406 | 0.060 |
Why?
|
| Boston | 1 | 2017 | 9371 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2008 | 14737 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 9063 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2012 | 1207 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4921 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 877 | 0.050 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 1188 | 0.050 |
Why?
|
| Radiography | 1 | 2014 | 6993 | 0.050 |
Why?
|
| Aged | 13 | 2020 | 171562 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 710 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 8075 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2007 | 961 | 0.050 |
Why?
|
| Middle Aged | 13 | 2020 | 223491 | 0.050 |
Why?
|
| Prescriptions | 1 | 2023 | 388 | 0.050 |
Why?
|
| Parotid Gland | 1 | 2022 | 178 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 848 | 0.040 |
Why?
|
| Male | 16 | 2020 | 364902 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13697 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 3411 | 0.040 |
Why?
|
| Workflow | 1 | 2023 | 859 | 0.040 |
Why?
|
| Health Facilities | 1 | 2023 | 577 | 0.040 |
Why?
|
| Neoplasms | 2 | 2018 | 22385 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 9198 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2018 | 8731 | 0.040 |
Why?
|
| Quality Control | 1 | 2001 | 833 | 0.040 |
Why?
|
| Female | 15 | 2020 | 397089 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 40272 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39407 | 0.030 |
Why?
|
| Observer Variation | 2 | 2016 | 2623 | 0.030 |
Why?
|
| Mammography | 1 | 2007 | 2434 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 21544 | 0.030 |
Why?
|
| Medical Errors | 1 | 2023 | 1263 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2005 | 1484 | 0.030 |
Why?
|
| Cisplatin | 1 | 2020 | 1661 | 0.030 |
Why?
|
| Equipment Design | 1 | 2002 | 3529 | 0.030 |
Why?
|
| Esophagectomy | 1 | 2018 | 482 | 0.030 |
Why?
|
| Data Mining | 1 | 2018 | 560 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 824 | 0.030 |
Why?
|
| Intestine, Large | 1 | 2012 | 69 | 0.020 |
Why?
|
| Rectum | 1 | 1997 | 902 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 9493 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1997 | 1261 | 0.020 |
Why?
|
| Defecation | 1 | 2012 | 191 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1997 | 1162 | 0.020 |
Why?
|
| Mediastinum | 1 | 2011 | 272 | 0.020 |
Why?
|
| Motivation | 1 | 2018 | 2029 | 0.020 |
Why?
|
| Health Surveys | 1 | 2017 | 4056 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2012 | 888 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 1655 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 74962 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 489 | 0.020 |
Why?
|
| Diarrhea | 1 | 2012 | 1320 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 4069 | 0.020 |
Why?
|
| Respiration | 1 | 2011 | 1667 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12870 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36849 | 0.010 |
Why?
|
| Palliative Care | 1 | 2017 | 3643 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 2005 | 541 | 0.010 |
Why?
|
| Lung Injury | 1 | 2007 | 433 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2005 | 824 | 0.010 |
Why?
|
| Gastrectomy | 1 | 2005 | 696 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 54920 | 0.010 |
Why?
|
| Physicians | 1 | 2017 | 4614 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3471 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 21162 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2296 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 2007 | 1204 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26375 | 0.010 |
Why?
|
| Massachusetts | 1 | 2012 | 8902 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 6241 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 30022 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 5103 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2008 | 2044 | 0.010 |
Why?
|
| Adult | 3 | 2018 | 223640 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1997 | 11221 | 0.010 |
Why?
|
| Quality of Life | 1 | 2012 | 13503 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 7064 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 7574 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 65379 | 0.000 |
Why?
|